1 (Image 1)
Topotecan Hydrochloride Injection, Powder, Lyophilized, For Solution
Product Images NDC 45963-615
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Topotecan Hydrochloride (NDC 45963-615). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
` (Image 2)
1 (Image 3)
This is a description of a medication called Topotecan. It comes in a lyophilized form in single-dose vials of 4mg. Each vial contains topotecan and other ingredients like mannitol, tartaric acid, sodium hydroxide and hydrochloric acid. It is for intravenous use only and caution must be exercised while handling it since it's a cytotoxic agent. The container does not have a prescription and it's sterile, non-pyrogenic, and has no preservatives. Dosage information is provided inside the package. The NDC for this medication is 45963-615-56.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
